What is it about?

While the significance of catatonic symptoms occurring in schizophrenia remains unclear, we review whether antipsychotics are as effective and safe in acute and chronic schizophrenia with catatonic symptoms compared to other treatments and compared to schizophrenia without catatonia.

Featured Image

Why is it important?

The validity of catatonia in schizophrenia is clinically significant only insofar as it predicts prognosis and response to treatment. Most contemporary clinical trials of antipsychotics have targeted schizophrenia as an overly broad unitary psychosis neglecting any differential response defined by phenomenology or course. However, early naturalistic studies showed that catatonia predicted poor response to first-generation antipsychotics in chronic schizophrenia and case reports cautioned against the risk of triggering neuroleptic malignant syndrome. More recent studies suggest that second-generation antipsychotics, particularly clozapine, may be effective in schizophrenia with catatonic symptoms, while unique randomized controlled trials that have not received sufficient coverage before have found that the short-term response to ECT may be faster and more significant. Based on available data, conclusions are limited as to whether antipsychotics are as effective and safe in acute and

Perspectives

This is an important and relatively neglected area covering available data on the predictive value of catatonic symptoms as a specific precision clinical marker in the treatment of schizophrenia.

Dr. Stanley N. Caroff
University of Pennsylvania

Read the Original

This page is a summary of: Treatment of schizophrenia with catatonic symptoms: A narrative review, Schizophrenia Research, November 2022, Elsevier,
DOI: 10.1016/j.schres.2022.11.015.
You can read the full text:

Read

Contributors

The following have contributed to this page